Waldenstrom's macroglobulinemia.

dc.contributor.authorSinghal, Nen_US
dc.contributor.authorBapsy, P Pen_US
dc.contributor.authorBabu, K Gen_US
dc.contributor.authorSahoo, T Pen_US
dc.date.accessioned2004-12-12en_US
dc.date.accessioned2009-05-30T23:23:44Z
dc.date.available2004-12-12en_US
dc.date.available2009-05-30T23:23:44Z
dc.date.issued2004-12-12en_US
dc.description19 references.en_US
dc.description.abstractWaldenstrom's macroglobulinemia is an uncommon lymphoplasmacytic lymphoma presenting with hyperviscocity and autoimmune phenomenon. Disease is characterized by bone marrow infiltration by lymphoplasmacytic cells and raised IgM. Bone marrow morphology and immunohistochemistry is important for diagnosis. Course is indolent and anemia and age are most important prognostic factors. Treatment options include alkylating agents, anti-purine anti-metabolites, which though not curative but offer valuable responses. Newer agents like Rituximab and autologous transplant are being tried.en_US
dc.description.affiliationDepartment of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore.en_US
dc.identifier.citationSinghal N, Bapsy PP, Babu KG, Sahoo TP. Waldenstrom's macroglobulinemia. Journal of the Association of Physicians of India. 2004 Dec; 52(): 981-5en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/90387
dc.language.isoengen_US
dc.source.urihttps://www.japi.orgen_US
dc.subject.meshAgeden_US
dc.subject.meshBone Marrow Cells --pathologyen_US
dc.subject.meshDiagnosis, Differentialen_US
dc.subject.meshHumansen_US
dc.subject.meshPrognosisen_US
dc.subject.meshWaldenstrom Macroglobulinemia --diagnosisen_US
dc.titleWaldenstrom's macroglobulinemia.en_US
dc.typeJournal Articleen_US
dc.typeReviewen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: